Adeoye Y. Olukotun, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 7,856 shares at $65.04 ($508K) on 2022-01-03, disclosed to the SEC on 2022-01-04.
Open-market sale of $508k ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.26 | 1,890 | $121K | 23.9% |
| 2 | $64.26 | 1,890 | $121K | 23.9% |
| 3 | $65.04 | 1,916 | $125K | 24.5% |
| 4 | $65.04 | 1,916 | $125K | 24.5% |
| 5 | $66.25 | 244 | $16K | 3.2% |
| Total | $64.70 avg | 7,856 |
| $508K |
| 100% |
| Filing → |
| ARWR | SELL | 2025-01-27 | $20K | — | Filing → |
| ARWR | SELL | 2024-12-30 | $57K | — | Filing → |
| ARWR | SELL | 2023-03-06 | $741K | — | Filing → |